1. Overview of Pharmaceutical Distribution Industry
1.1 Definition
1.2 Industry Chain
1.3 Strength and Weakness of Pharmaceutical Chain Enterprises
1.3.1 Strength of Pharmaceutical Chain Enterprises
1.3.2 Weakness of Pharmaceutical Chain Enterprises

2. Pharmaceutical Distribution Industry in China
2.1 Development Environment
2.1.1 Policy
2.1.2 Economy
2.1.3 Medical Institution
2.1.4 Health Expenditure
2.1.5 Aging
2.1.6 Per Capita Disposable Income
2.2 Status Quo
2.3 Market Size
2.4 Market Structure
2.5 Competitive Landscape
2.6 Development Trends
2.6.1 Pharmaceutical E-commerce Becomes an Important Model
2.6.2 Operating Efficiency and Service Functions Gets Improved Constantly
2.6.3 Capital Market Plays a Bigger Role in Integration of Enterprises
2.6.4 Pharmaceutical Supply-chain Management Services Are Upgraded Rapidly
2.6.5 Cross-border Integration of Pharmaceuticals and E-commerce Continues
2.6.6 Favorable Policies Make the Market More Concentrated
2.6.7 Growing Trend towards Regionalization
2.6.8 Wholesale-retail Integration Spurs Industry Consolidation
2.6.9 Outflow of Prescriptions is a Boon for the Industry
2.6.10 Single Drugstores are Being Edged out by Drugstore Chains Which are Gaining Ground

3 Chinese Drug Retail Market
3.1 Market Size
3.2 Gross Margin and Net Margin
3.3 Quantity
3.3.1 Top100 Pharmacy Chains
3.3.2 Online Pharmacy
3.3.3 Independent Pharmacy
3.3.4 Shares of New Stores and Those Shut down
3.4 Share of Medical Insurance Designated Stores
3.5 Per Customer Transaction
3.6 Comparison of Operating Results between Major Drug Retailers

4. Major Enterprises
4.1 China National Accord Medicines Corporation Ltd.
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Major Customers
4.1.5 Pharmaceutical Distribution Business
4.1.6 Development Strategy
4.2 Nanjing Pharmaceutical Co., Ltd.
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Gross Margin
4.2.5 Development Strategy
4.3 Shanghai No.1 Pharmacy Co., Ltd.
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 Development Strategy
4.4 China National Medicines Corporation Ltd.
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5 Development Strategy
4.5 Huadong Medicine Co., Ltd.
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Gross Margin
4.5.5 Major Customers
4.5.6 Development Strategy
4.6 Cachet Pharmaceutical Co., Ltd.
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.6.4 Gross Margin
4.6.5 Major Customers
4.6.6 Development Strategy
4.7 Jointown Pharmaceutical Group Co., Ltd.
4.7.1 Profile
4.7.2 Operation
4.7.3 Revenue Structure
4.7.4 Gross Margin
4.7.5 Major Customers
4.7.6 Development Strategy
4.8 Realcan Pharmaceutical Co., Ltd.
4.8.1 Profile
4.8.2 Operation
4.8.3 Revenue Structure
4.8.4 Gross Margin
4.8.5 Development Strategy
4.9 Shanghai Pharmaceuticals Holding Co., Ltd.
4.9.1 Profile
4.9.2 Operation
4.9.3 Revenue Structure
4.9.4 Gross Margin
4.9.5 Development Strategy
4.10 Zhejiang Int’l Group Co., Ltd.
4.10.1 Profile
4.10.2 Operation
4.10.3 Revenue Structure
4.10.4 Gross Margin
4.10.5 Development Strategy
4.11 Zhejiang Zhenyuan Share Co., Ltd.
4.11.1 Profile
4.11.2 Operation
4.11.3 Revenue Structure
4.11.4 Gross Margin
4.11.5 Development Strategy
4.12 China Meheco Co., Ltd.
4.12.1 Profile
4.12.2 Operation
4.12.3 Revenue Structure
4.12.4 Gross Margin
4.12.5 Development Strategy
4.13 Charmacy Pharmaceutical Co., Ltd.
4.13.1 Profile
4.13.2 Operation
4.13.3 Revenue Structure
4.13.4 Gross Margin
4.13.5 Development Strategy
4.14 Luyan Pharma Co., Ltd.
4.14.1 Profile
4.14.2 Operation
4.14.3 Revenue Structure
4.14.4 Gross Margin
4.14.5 Development Strategy
4.15 China Resources Pharmaceutical Group Limited
4.15.1 Profile
4.15.2 Operation
4.15.3 Revenue Structure
4.15.4 Gross Margin
4.15.5 Development Strategy
4.16 DaShenLin Pharmaceutical Group Co., Ltd.
4.16.1 Profile
4.16.2 Operation
4.16.3 Revenue Structure
4.16.4 Gross Margin
4.16.5 Development Strategy
4.17 Yunnan Jianzhijia Health Chain Co., Ltd.
4.17.1 Profile
4.17.2 Operation
4.17.3 Revenue Structure
4.17.4 Gross Margin
4.17.5 Development Strategy
4.18 Yifeng Pharmacy Chain Co., Ltd.
4.18.1 Profile
4.18.2 Operation
4.18.3 Revenue Structure
4.18.4 Gross Margin
4.18.5 Development Strategy
4.19 Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd.
4.19.1 Profile
4.19.2 Operation
4.19.3 Revenue Structure
4.19.4 Gross Margin
4.19.5 Development Strategy
4.20 LBX Pharmacy Chain co., Ltd
4.20.1 Profile
4.20.2 Operation
4.20.3 Revenue Structure
4.20.4 Gross Margin
4.20.5 Development Strategy